Igen in expansion mode
This article was originally published in Clinica
Igen has opened new facilities in the US and Europe, expanded a homeland defence agreement it has with the US Department of Agriculture, and is pursuing further partnerships in a drive to expand its business.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.